Evelo Biosciences News - EVLO

Company Name	Stock Ticker Symbol	Market	Type
Evelo Biosciences Inc	EVLO	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.00	0.00%	0.3165	20:00:00

Open Price	Low Price	High Price	Close Price	Prev Close
			0.3165	0.3165

more quote information »

Recent News

Date	Time	Source	Heading
1/26/2024	17:30	EDGAR2	Form 15-12G - Securities registration termination [Section..
1/26/2024	17:29	EDGAR2	Form S-8 POS - Securities to be offered to employees in..
1/26/2024	17:27	EDGAR2	Form POS AM - Post-Effective amendments for registration..
1/26/2024	17:26	EDGAR2	Form 8-K - Current report
12/12/2023	07:43	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
12/12/2023	07:42	EDGAR2	Form DEF 14A - Other definitive proxy statements
12/04/2023	06:04	EDGAR2	Form 8-K - Current report
12/01/2023	07:11	EDGAR2	Form PRE 14A - Other preliminary proxy statements
11/21/2023	06:44	EDGAR2	Form 8-K - Current report
11/09/2023	17:06	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/08/2023	20:32	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/08/2023	20:32	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/08/2023	20:31	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/03/2023	16:12	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/03/2023	16:11	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/03/2023	16:11	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/27/2023	17:24	EDGAR2	Form 8-K - Current report
10/17/2023	07:05	EDGAR2	Form 8-K - Current report
10/17/2023	07:00	GLOBE	Evelo Biosciences Announces Top-Line Results From its Phase..
9/13/2023	20:55	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/13/2023	20:55	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/13/2023	20:54	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/21/2023	17:25	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
8/21/2023	07:43	EDGAR2	Form 8-K - Current report
8/18/2023	00:15	EDGAR2	Form EFFECT - Notice of Effectiveness
8/14/2023	08:14	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/14/2023	07:42	EDGAR2	Form 8-K - Current report
8/14/2023	07:30	GLOBE	Evelo Biosciences Announces Second Quarter Financial Results..
8/10/2023	16:02	EDGAR2	Form S-3 - Registration statement under Securities Act of..
8/09/2023	20:44	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/09/2023	20:42	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/09/2023	20:42	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/20/2023	16:21	EDGAR2	Form 8-K - Current report
7/18/2023	07:27	IHMARKETNEWS	Tuesday’s Wall Street Highlights: Novartis, BofA, Dollar..
7/12/2023	16:08	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/12/2023	16:06	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
7/12/2023	07:55	EDGAR2	Form 8-K - Current report
7/12/2023	07:30	GLOBE	Evelo Biosciences Closes $25.5 Million Private Placement
7/10/2023	07:36	EDGAR2	Form 8-K - Current report
7/10/2023	07:30	GLOBE	Evelo Biosciences Announces $25.5 Million Private Placement
7/07/2023	16:06	EDGAR2	Form 8-K - Current report
6/29/2023	17:10	EDGAR2	Form 8-K - Current report
6/29/2023	09:00	GLOBE	Evelo Biosciences Announces Reverse Stock Split Effective
5/16/2023	06:00	PRNUS	Flagship Pioneering Launches Metaphore Biotechnologies to..